Medicine is rapidly shifting from a traditional one-size-fits-all approach to diagnosis and treatment, to an individualized predictive and personalized medicine model with care customized for each patient. Uniquely positioned within this shifting healthcare paradigm are molecular and clinical laboratories that can provide healthcare teams with access to a rich repository of actionable genetic data.
Pathologists are becoming the point persons as personalized medicine becomes the norm, and as the understanding of the relationship between genetic variants and disease continues to grow. With next generation sequencing (NGS) accelerating the pace of discoveries, prevention and treatment will no longer be centered around “standards of care” that often result in a predetermined sequence of therapies. Instead, a patient’s genome, lifestyle, and environment will combine to pinpoint an effective and individualized treatment plan.
Because NGS is the engine powering much of this new genetic information and igniting the potential of personalized medicine, clinical laboratories have an ideal opportunity to add clinical value and generate a new revenue source by adopting NGS technologies. But—because the NGS modality places significant demands on most current laboratory information systems (LIMS) and leaves them lacking crucial functionality—labs need to have in place a LIMS specifically designed to accommodate personalized medicine’s informatics integration and workflow challenges in order to successfully integrate NGS.
The Dark Report is pleased to offer this FREE White Paper—your guide to understanding the potential that NGS technology holds for your laboratory, as well as how you can realize this potential and convert it into reality by having the right tools in place.
This White Paper provides you with a detailed discussion regarding:
- The growing role of NGS in clinical care
- NGS’ return on investment for clinical and molecular laboratories
- The role of pathologists, as NGS accelerates the transition to predictive and personalized medicine
- The information technology and tools laboratories need to successfully offer NGS-based services
- Benefits of outsourcing annotation and interpretation of gene sequences and test-result reporting
- What clinical and molecular laboratories need to know about marketing NGS services to new and existing clients
Table of Contents
Chapter 1: Why Next-Generation Sequencing Has a Growing Role in Clinical Care
Chapter 2: How Clinical and Molecular Laboratories Can Establish NGS Services That Deliver Value to Physicians and Patients
Chapter 3: What Pathologists and PhDs Need to Know about Helping Physicians Understand the Value of NGS in Diagnosing Patients, Selecting Best Therapies, and Monitoring Patient Progress
Chapter 4: What Information Technology and Informatics Capabilities Do Clinical and Molecular Laboratories Need to Succeed with NGS-based Services?
Chapter 5: MIMS’ The Benefits of Outsourcing Annotation and Interpretation of Gene Sequences and Test Results in Support of Patient Care
Chapter 6: What Clinical and Molecular Laboratories Need to Know about Marketing NGS Services and Using NGS to Retain Existing Clients
Medicine is transforming from reactive to proactive, predictive care, with NGS on the verge of being transformative in many ways as it provides a direction destined to accelerate the shift in care models, and ushers in personalized medicine at the genomic level.
This White Paper discusses the growing role of NGS in clinical care and its potential to fuel the transformation to predictive and proactive medicine, as well as pathologists’ contributions to this emerging paradigm and the laboratory information technology and informatics they will need to remain at the forefront of change.
Understanding that NGS services represent a major financial commitment by laboratories, the advantages of using NGS testing as a tool to retain and grow a lab’s customer base is also examined, as is the importance of purchasing a best-of-breed molecular LIS created with big data, genome annotation and interpretation, and informed decision-making in mind.
Pathologists are uniquely qualified to advance the cause of personalized medicine among regulators, insurers, providers, and patients, but can only do so if the best health informatics technology is at their fingertips.
To learn more, download your FREE copy of “How Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians.”
Download the White Paper now by completing the form below.